Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05275439
Title Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Shattuck Labs, Inc.
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

Azacitidine + SL-172154 + Venetoclax

Azacitidine + SL-172154

SL-172154

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST